News

Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.

Opinion follows review of additional data and advice from group of experts.

Ulla Wändel Liminga will begin her three-year mandate in September 2024

New appointments in the Legal Department and the Regulatory Science and Innovation Task Force

Eurneffy (epinephrine) is an alternative to injectable formulations

Winrevair received support through PRIority Medicines (PRIME) scheme due to its potential to bring a major therapeutic advantage over existing therapies

Benefits of Ocaliva no longer considered to outweigh its risks